237 related articles for article (PubMed ID: 26277104)
21. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.
Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H
Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153
[TBL] [Abstract][Full Text] [Related]
22. Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability.
Benabdallah NS; Dalal V; Scott RW; Marcous F; Sotiriou A; Kommoss FKF; Pejkovska A; Gaspar L; Wagner L; Sánchez-Rivera FJ; Ta M; Thornton S; Nielsen TO; Underhill TM; Banito A
Nat Struct Mol Biol; 2023 Nov; 30(11):1640-1652. PubMed ID: 37735617
[TBL] [Abstract][Full Text] [Related]
23. Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy.
Nielsen TO; Poulin NM; Ladanyi M
Cancer Discov; 2015 Feb; 5(2):124-34. PubMed ID: 25614489
[TBL] [Abstract][Full Text] [Related]
24. The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma.
Banito A; Li X; Laporte AN; Roe JS; Sanchez-Vega F; Huang CH; Dancsok AR; Hatzi K; Chen CC; Tschaharganeh DF; Chandwani R; Tasdemir N; Jones KB; Capecchi MR; Vakoc CR; Schultz N; Ladanyi M; Nielsen TO; Lowe SW
Cancer Cell; 2018 Mar; 33(3):527-541.e8. PubMed ID: 29502955
[TBL] [Abstract][Full Text] [Related]
25. Frequent TRPS1 expression in synovial sarcoma is associated with SS18-SSX fusion oncoprotein activity.
Cloutier JM; Ingram DR; Wani K; Lazar AJ; Wang WL
Hum Pathol; 2022 Dec; 130():88-94. PubMed ID: 36162599
[TBL] [Abstract][Full Text] [Related]
26. SS18-SSX drives CREB activation in synovial sarcoma.
Cyra M; Schulte M; Berthold R; Heinst L; Jansen EP; Grünewald I; Elges S; Larsson O; Schliemann C; Steinestel K; Hafner S; Simmet T; Wardelmann E; Kailayangiri S; Rossig C; Isfort I; Trautmann M; Hartmann W
Cell Oncol (Dordr); 2022 Jun; 45(3):399-413. PubMed ID: 35556229
[TBL] [Abstract][Full Text] [Related]
27. A novel fusion gene, SS18L1/SSX1, in synovial sarcoma.
Storlazzi CT; Mertens F; Mandahl N; Gisselsson D; Isaksson M; Gustafson P; Domanski HA; Panagopoulos I
Genes Chromosomes Cancer; 2003 Jun; 37(2):195-200. PubMed ID: 12696068
[TBL] [Abstract][Full Text] [Related]
28. SS18-SSX Expression in a Contemporary Cohort of Primary Renal Synovial Sarcoma: A Multi-Institutional Experience of Fourteen Patients.
Challa B; Mohanty SK; Jha S; Sampat NY; Sardana R; Lobo A; Sharma S; Arora S; Rath D; Munjal G; Pattnaik N; Jain D; Jain E; Dewan A; Dixit M; Malik V; Shinde S; Balzer BL; Parwani A
Int J Surg Pathol; 2023 Oct; 31(7):1232-1243. PubMed ID: 36591871
[TBL] [Abstract][Full Text] [Related]
29. Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
Carmody Soni EE; Schlottman S; Erkizan HV; Uren A; Toretsky JA
Clin Orthop Relat Res; 2014 Mar; 472(3):874-82. PubMed ID: 23716114
[TBL] [Abstract][Full Text] [Related]
30. The (epi)genetics of human synovial sarcoma.
de Bruijn DR; Nap JP; van Kessel AG
Genes Chromosomes Cancer; 2007 Feb; 46(2):107-17. PubMed ID: 17117414
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel SSX1 fusions in synovial sarcoma.
Yoshida A; Arai Y; Satomi K; Kubo T; Ryo E; Matsushita Y; Hama N; Sudo K; Komiyama M; Yatabe Y; Shibata T; Ichikawa H; Ichimura K; Kawai A; Mori T
Mod Pathol; 2022 Feb; 35(2):228-239. PubMed ID: 34504309
[TBL] [Abstract][Full Text] [Related]
32. Differential roles of SS18-SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth.
Törnkvist M; Natalishvili N; Xie Y; Girnita A; D'Arcy P; Brodin B; Axelson M; Girnita L
Biochem Biophys Res Commun; 2008 Apr; 368(3):793-800. PubMed ID: 18267106
[TBL] [Abstract][Full Text] [Related]
33. Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
Kawano S; Grassian AR; Tsuda M; Knutson SK; Warholic NM; Kuznetsov G; Xu S; Xiao Y; Pollock RM; Smith JS; Kuntz KK; Ribich S; Minoshima Y; Matsui J; Copeland RA; Tanaka S; Keilhack H
PLoS One; 2016; 11(7):e0158888. PubMed ID: 27391784
[TBL] [Abstract][Full Text] [Related]
34. [Expression of SS18-SSX fusion-specific antibody and SSX C-terminal antibody in synovial sarcoma and its diagnostic value].
Wang X; Cheng K; Wu N; Li R; Chen H; Ma HH; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):740-744. PubMed ID: 34405607
[No Abstract] [Full Text] [Related]
35. Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma.
Mihály D; Nagy N; Papp G; Pápai Z; Sápi Z
Diagn Pathol; 2018 Oct; 13(1):81. PubMed ID: 30326929
[TBL] [Abstract][Full Text] [Related]
36. Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.
Kadoch C; Crabtree GR
Cell; 2013 Mar; 153(1):71-85. PubMed ID: 23540691
[TBL] [Abstract][Full Text] [Related]
37. Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics.
Su L; Sampaio AV; Jones KB; Pacheco M; Goytain A; Lin S; Poulin N; Yi L; Rossi FM; Kast J; Capecchi MR; Underhill TM; Nielsen TO
Cancer Cell; 2012 Mar; 21(3):333-47. PubMed ID: 22439931
[TBL] [Abstract][Full Text] [Related]
38. Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases.
Przybyl J; Sciot R; Rutkowski P; Siedlecki JA; Vanspauwen V; Samson I; Debiec-Rychter M
Tumour Biol; 2012 Dec; 33(6):2245-53. PubMed ID: 22976541
[TBL] [Abstract][Full Text] [Related]
39. Synovial Sarcoma Oncogenesis Revealed by Single-Cell Profiling.
Qiu A; Nielsen TO
Trends Cancer; 2021 Jun; 7(6):482-483. PubMed ID: 33893065
[TBL] [Abstract][Full Text] [Related]
40. Immunoreactivity of a Monoclonal Antibody to SS18-SSX Fusion Gene Product in Formalin-fixed Paraffin-embedded Synovial Sarcoma Tissue Section.
Saigo C; Kito Y; Takeuchi T
Appl Immunohistochem Mol Morphol; 2018 Mar; 26(3):206-211. PubMed ID: 27362474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
